Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01119430

Recruitment Status : Terminated (interim analysis suggested no differences with whole sample)

First Posted : May 7, 2010

Last Update Posted : May 7, 2010

Sponsor:

Information provided by:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	November 2007
Actual Study Completion Date :	November 2007

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol. 2012 Nov;167(5):1021-34. doi: 10.1111/j.1476-5381.2011.01770.x.

To Top